Prof Richard Sullivan
Cited by
Cited by
Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development
JG Meara, AJM Leather, L Hagander, BC Alkire, N Alonso, EA Ameh, ...
The lancet 386 (9993), 569-624, 2015
The burden of disease in older people and implications for health policy and practice
MJ Prince, F Wu, Y Guo, LMG Robledo, M O'Donnell, R Sullivan, S Yusuf
The lancet 385 (9967), 549-562, 2015
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
C Maringe, J Spicer, M Morris, A Purushotham, E Nolte, R Sullivan, ...
The lancet oncology 21 (8), 1023-1034, 2020
Economic burden of cancer across the European Union: a population-based cost analysis
R Luengo-Fernandez, J Leal, A Gray, R Sullivan
The lancet oncology 14 (12), 1165-1174, 2013
The global burden of women’s cancers: a grand challenge in global health
O Ginsburg, F Bray, MP Coleman, V Vanderpuye, A Eniu, SR Kotha, ...
The Lancet 389 (10071), 847-860, 2017
Mortality due to cancer treatment delay: systematic review and meta-analysis
TP Hanna, WD King, S Thibodeau, M Jalink, GA Paulin, E Harvey-Jones, ...
bmj 371, 2020
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical …
NI Cherny, R Sullivan, U Dafni, JM Kerst, A Sobrero, C Zielinski, ...
Annals of Oncology 26 (8), 1547-1573, 2015
Delivering affordable cancer care in high-income countries
R Sullivan, J Peppercorn, K Sikora, J Zalcberg, NJ Meropol, E Amir, ...
The lancet oncology 12 (10), 933-980, 2011
Planning cancer control in Latin America and the Caribbean
PE Goss, BL Lee, T Badovinac-Crnjevic, K Strasser-Weippl, ...
The lancet oncology 14 (5), 391-436, 2013
Global cancer surgery: delivering safe, affordable, and timely cancer surgery
R Sullivan, OI Alatise, BO Anderson, R Audisio, P Autier, A Aggarwal, ...
The lancet oncology 16 (11), 1193-1224, 2015
Medicinal mushrooms
J Smith, N Rowan, R Sullivan
Their therapeutic properties and current medical usage with special emphasis …, 2002
Challenges to effective cancer control in China, India, and Russia
PE Goss, K Strasser-Weippl, BL Lee-Bychkovsky, L Fan, J Li, ...
The lancet oncology 15 (5), 489-538, 2014
The growing burden of cancer in India: epidemiology and social context
MK Mallath, DG Taylor, RA Badwe, GK Rath, V Shanta, CS Pramesh, ...
The Lancet Oncology 15 (6), e205-e212, 2014
Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine
R Sullivan, JE Smith, NJ Rowan
Perspectives in biology and medicine 49 (2), 159-170, 2006
Medicinal mushrooms: a rapidly developing area of biotechnology for cancer therapy and other bioactivities
JE Smith, NJ Rowan, R Sullivan
Biotechnology letters 24 (22), 1839-1845, 2002
Economic burden of bladder cancer across the European Union
J Leal, R Luengo-Fernandez, R Sullivan, JA Witjes
European urology 69 (3), 438-447, 2016
Medicinal Mushrooms and Cancer
JE Smith, NJ Rowan, R Sullivan
Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer …
AG Lai, L Pasea, A Banerjee, G Hall, S Denaxas, WH Chang, M Katsoulis, ...
BMJ open 10 (11), e043828, 2020
Medicinal Mushrooms: Their Therapeutic Properties and Current Medical Usage with Special Emphasis on Cancer Treatment; Special Report Commissioned by Cancer Research UK
J Smith, N Rowan, R Sullivan
The University of Strathclyde in Glasgow 5 (3), 235-46, 2003
Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity
GYK Ng, J Clark, N Coulombe, N Ethier, TE Hebert, R Sullivan, ...
Journal of Biological Chemistry 274 (12), 7607-7610, 1999
The system can't perform the operation now. Try again later.
Articles 1–20